PUBLICATIONS
|
|
HEALTH INFORMATION TECHNOLOGY USE & VALUE DELIVERED BY THE LTPAC SECTOR - MAY 2015 (http://www.ltpachealthit.org/sites/default/files/ONC%20Brief%20LTPAC%20HIT%20Value%20and%20Use_May%201%202015.pdf) - This published paper was orchestrated by John Derr at the request of ONC Dr. DeSalvo. She asked that she receive information on LTPAC. The Association Members of the LTPAC Health IT Collaborative participated in the writing of the Brief and developed the Value Quality Coordination of Care (VQCC) Differentials to other providers in the Spectrum of Care like hospitals and physician offices.
|
|
MCKNIGHT'S TECHNOLOGY: CHANGING THE FUTURE - JUNE 2016http://media.mcknights.com/documents/236/2016_it_supplement_final_optim_58943.pdf
Derr contributed this this report and was quoted a number of times: “It’s all about survival,” says John Derr, R.Ph., a former AHCA and Golden Living executive who co- founded the LTPAC Health IT Collaborative. “Because of all the new care, payment, and clinical regulations, senior living operators have to have up- to-date technology to play in the Medicare/Medicaid world. And if you cannot play, you will go bankrupt.” “All of these little (independent) operators don’t really have the level of sophistication yet to ward off these kinds of hack attempts,” says John Derr, R.Ph., a former AHCA and Golden Living execu- tive who co-founded the LTPAC Health IT Collaborative. Dustin Scholz, senior director over senior living and skilled nursing operations for The Evangelical Lutheran Good Samaritan Society, agrees. “I don’t think senior liv- ing is ‘getting it’ yet,” observes Derr. “Their IT departments are still ‘in the basement.’ And all of that clinical information is a bit discordant. They’re under a lot of pressure. What’s going on at the national level doesn’t really reach that level where it needs to be. “The top LTPAC health IT vendors are investing millions of dollars in analytics and pro- jecting outcomes,” Derr adds. “Are senior living operators able to make strategic decisions with health IT? We’re not there yet.” |
|
VPMONITOR ARTICLES ON THE VALUE PROPOSITION OF LTPAC - 2015 - Current - (http://www.vbpmonitor.com/index.php/news/item/166-valued-quality-of-care-coordination-vqcc-technology-differential) John Derr is writing an article for VPMonitror website an average of one per month. The current series has a focus on the May 2015 ONC Brief that was provided to the HHS Deputy Secretary of Health and ONC Dr. Karen DeSalvo. VPMonitor has decided to have a focus on LTPAC. You can see the Derr articles when you search
Derr on the website. (See the ONC Brief Publication above) |
LTPAC HIT COLLABORATIVE HEALTH IT ROADMAPS 2005 - 2014 - One of the important publications that I have helped to write is the LTPAC HIT Roadmap. This Roadmap is in Harmony with the ONC Strategic Plan. The 5th Revision for 2015-2016 will be presented at the 2014 Annual LTPAC HIT Summit to be held in Baltimore June 24-25, 2014. You can register to attend the 2014 by either logging in at the AHMIA or the LTPAC Websites listed on the Website
DEVELOPING QUALITY MEASURES FOR LONGITUDINAL CARE - 2012 - 2013 AHIMA - (http://bok.ahima.org/doc?oid=105667#.V5EHEleG938) T O’Malley, MD Chief Medical Officer of Boston Partners and Derr wrote three papers on eQuality Measurements in Longitudinal Care for the AHIMA Journal. these articles pointed out the need for chronic care eQuality Measures for chronic care patients with co-morbidities and not just single disease QMs. In today's marketplace there are many quality organizations creating QMs. Almost all of these quality measures are facility oriented. Once we have person centric electronic longitudinal care the eQMs have to cross care setting lines and be dedicated to a patient. Within a facility the person centric eQMs can be aggregated to make a facility measurement.
Long Term Living IT BLOG - In 2012 - 13 Derr wrote a monthly BLOG on health information technology. The articles were positioned to assist small skilled nursing facilities to prepare for the new world of healthcare
AHCA Provider Magazine IT Articles - When Derr was the COO of AHCA/NCAL he formed the AHC IT Committee. During the years 2003-2006 he wrote a series of articles on technology the role technology will play in the future of healthcare.
DEVIL TREE by John Frederick Derr, R.Ph. - INTERNATIONAL PHARMACEUTICAL ESPIONAGE
A cure for Alzheimer’s Becomes a Factor in the Corporate Board Room
(Washington, DC)— John Frederick Derr announced the publishing of the fictional novel, Devil Tree. Devil Tree takes the reader through a maze of international intrigue as the world of a leading pharmaceutical company is challenged from both internal and external forces as it struggles to survive a take over. The bark of the Devil Tree (common name of the Indonesian Alstonia Spectabilis tree) is used for traditional medicine but in this story it is discovered to have Alzheimer’s curative powers.
James Pharmaceutical Company, Inc. James Pharmaceutical Company (JPC) is on the verge of a colossal breakthrough in the world of pharmaceuticals: a cure for Alzheimer’s disease. JPC has developed the formula, but cannot perfect the product due to a milky sap that is rich in poisonous alkaloids as well as a shortage in working capital.
When the president of JPC discovers that an unknown yet trusted key employee has made a copy of a secret document outlining the cure at a Doylestown, PA, he calls in a favor from his old fried, Jean Paul Koenig, PhD. Jean Paul or J.P., an expert in herbal pharmaceuticals, reluctantly agrees to get involved. Along the way J.P. befriends a Japanese intelligence officer who has been trying to find a new product for a small innovative Japanese pharmaceutical company in Bandai, Japan. Together they evaluate the situation and work through deceit and violence as major international pharmaceutical companies fight for the highly coveted pharmaceutical, its raw material, and the rights to market it.
The opening takes place in Stover Park outside Doylestown, PA where JP is being pursued by agents of a foreign corporation. Within the story there is a breakfast meeting at the Black Bass Hotel in Lumberville, PA
The investigating team, including the lovely Vice President of Marketing for JPC, Mandi travel from New York City, Los Angeles, Mammoth Lakes, CA, Japan, Singapore, and Indonesia to find the thief and why the document was stolen.
J.P. looked into the limo and directly into ------- eyes. Once their eyes locked in a common stare ------- closed his eyes and lowered his head.
“Don’t you close your eyes to me, look at me.” J.P. commanded. ------- opened his eyes. J.P. continued, “I will assume that I will never see you again in my lifetime. I encourage you never to attempt to enter the US marketplace with your unethical tactics. You bring shame on an honorable profession and the Japanese people. It is you and your associates’ type of business conduct that keeps the world on the edge of trade warfare. You hide behind your honored culture and the free enterprise system when greed and power alone motivate you. You use immoral techniques to gain what you want to control and then you throw our business honesty back into our faces. Learn from today. Learn from Dr. Nakasone and Mr. Nacheda. They do your industry and Japan proud. ……. You probably don’t understand a word that I am saying so I will end my short lecture with a final warning. Stay out of my way.”
If the potential reader wants to learn about what possibly goes on in the Board Room and research department of a pharmaceutical company they have to read Devil Tree.
Devil Tree is available in hard back and soft cover at www.Amazon.com and www.Barnesandnoble.com
ISBN – 13: 978-0-595-35703-1
A cure for Alzheimer’s Becomes a Factor in the Corporate Board Room
(Washington, DC)— John Frederick Derr announced the publishing of the fictional novel, Devil Tree. Devil Tree takes the reader through a maze of international intrigue as the world of a leading pharmaceutical company is challenged from both internal and external forces as it struggles to survive a take over. The bark of the Devil Tree (common name of the Indonesian Alstonia Spectabilis tree) is used for traditional medicine but in this story it is discovered to have Alzheimer’s curative powers.
James Pharmaceutical Company, Inc. James Pharmaceutical Company (JPC) is on the verge of a colossal breakthrough in the world of pharmaceuticals: a cure for Alzheimer’s disease. JPC has developed the formula, but cannot perfect the product due to a milky sap that is rich in poisonous alkaloids as well as a shortage in working capital.
When the president of JPC discovers that an unknown yet trusted key employee has made a copy of a secret document outlining the cure at a Doylestown, PA, he calls in a favor from his old fried, Jean Paul Koenig, PhD. Jean Paul or J.P., an expert in herbal pharmaceuticals, reluctantly agrees to get involved. Along the way J.P. befriends a Japanese intelligence officer who has been trying to find a new product for a small innovative Japanese pharmaceutical company in Bandai, Japan. Together they evaluate the situation and work through deceit and violence as major international pharmaceutical companies fight for the highly coveted pharmaceutical, its raw material, and the rights to market it.
The opening takes place in Stover Park outside Doylestown, PA where JP is being pursued by agents of a foreign corporation. Within the story there is a breakfast meeting at the Black Bass Hotel in Lumberville, PA
The investigating team, including the lovely Vice President of Marketing for JPC, Mandi travel from New York City, Los Angeles, Mammoth Lakes, CA, Japan, Singapore, and Indonesia to find the thief and why the document was stolen.
J.P. looked into the limo and directly into ------- eyes. Once their eyes locked in a common stare ------- closed his eyes and lowered his head.
“Don’t you close your eyes to me, look at me.” J.P. commanded. ------- opened his eyes. J.P. continued, “I will assume that I will never see you again in my lifetime. I encourage you never to attempt to enter the US marketplace with your unethical tactics. You bring shame on an honorable profession and the Japanese people. It is you and your associates’ type of business conduct that keeps the world on the edge of trade warfare. You hide behind your honored culture and the free enterprise system when greed and power alone motivate you. You use immoral techniques to gain what you want to control and then you throw our business honesty back into our faces. Learn from today. Learn from Dr. Nakasone and Mr. Nacheda. They do your industry and Japan proud. ……. You probably don’t understand a word that I am saying so I will end my short lecture with a final warning. Stay out of my way.”
If the potential reader wants to learn about what possibly goes on in the Board Room and research department of a pharmaceutical company they have to read Devil Tree.
Devil Tree is available in hard back and soft cover at www.Amazon.com and www.Barnesandnoble.com
ISBN – 13: 978-0-595-35703-1